- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01291485
Electronic Intervention for HIV Medication Adherence
October 9, 2012 updated by: Kasey Claborn, Oklahoma State University Center for Health Sciences
Randomized Clinical Trial Examining the Efficacy of an Electronic Intervention for HIV Medication Adherence
The purpose of this study is to develop and examine the feasibility and initial efficacy of a computer-based intervention to improve medication adherence among people living with HIV.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
97
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Oklahoma
-
Tulsa, Oklahoma, United States, 74127
- Internal Medicine Specialty Services
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- infected with HIV
- over age 18
- currently prescribed a Highly Active Antiretroviral Therapy (HAART) regimen
- prescribed a regimen for the first time, changing regimens, or report adherence below 95% agree to brief follow-up interviews
Exclusion Criteria:
- physical impairment that would prevent them from successfully completing the computer-based program (e.g., blind, deaf, severe neuropsychological impairment)
- Actively psychotic
- Not fluent in English
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Treatment as Usual
|
|
Experimental: Lifestyle counseling
Intervention includes education about HIV and medication adherence, motivational interviewing, cognitive behavioral techniques, and problem-solving strategies to improve HIV medication adherence and clinical outcomes.
|
The intervention was adapted into an electronic version of the empirically supported Life Steps intervention for HIV medication adherence.
Education about HIV and medication adherence, motivational interviewing, cognitive behavioral techniques, and problem-solving strategies to improve medication adherence and clinical outcomes in people living with HIV were also included in the intervention.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
HIV medication adherence
Time Frame: up to 6 months
|
Self-reported adherence to HIV medications will be assessed using the AACTG Medication Adherence Questionnaire (M. A. Chesney, et al., 2000).
|
up to 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
HIV Treatment Adherence Self-Efficacy
Time Frame: Baseline, 1-month, 3 months, and 6-months
|
Self-efficacy for adherence to HIV medications will be assessed using the HIV-ASES (Johnson et al., 2007).
The HIV-ASES is a 12-item scale of patient confidence in their ability to carry out behaviors related to adhering to medication regimens.
Responses range from 1 ("cannot do it at all") to 10 ("completely certain can do it").
Item scores are averaged with higher scores indicating higher adherence self-efficacy.
|
Baseline, 1-month, 3 months, and 6-months
|
Quality of Life
Time Frame: Baseline, 1-month, 3-months, and 6-months
|
Quality of life will be assessed using the McGill Quality of Life questionnaire (S.
Robin Cohen, Hassan, Lapointe, & Mount, 1996).
This instrument is a 16-item scale that assesses quality of life in four domains: physical well-being, psychological well-being, existential well-being, and support; each item is assessed on a 0-10 point scale.
|
Baseline, 1-month, 3-months, and 6-months
|
Viral Load
Time Frame: Baseline, 1 month, 3 months, and 6 months
|
Baseline, 1 month, 3 months, and 6 months
|
|
CD4 cell count
Time Frame: Baseline, 1 month, 3 months, and 6 months
|
Baseline, 1 month, 3 months, and 6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Thad R Leffingwell, Ph.D., Oklahoma State University
- Principal Investigator: Kasey R Claborn, M.S., Oklahoma State University
- Study Chair: Johnny Stephens, Pharm.D., Oklahoma State University Center for Health Sciences
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2011
Primary Completion (Actual)
September 1, 2011
Study Completion (Actual)
November 1, 2011
Study Registration Dates
First Submitted
January 10, 2011
First Submitted That Met QC Criteria
February 7, 2011
First Posted (Estimate)
February 8, 2011
Study Record Updates
Last Update Posted (Estimate)
October 10, 2012
Last Update Submitted That Met QC Criteria
October 9, 2012
Last Verified
October 1, 2012
More Information
Terms related to this study
Other Study ID Numbers
- 2010022
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV
-
University of Alabama at BirminghamMobile County Health Deparment; Alabama Department of Public HealthRecruitingHIV | HIV Testing | HIV Linkage to Care | HIV TreatmentUnited States
-
French National Agency for Research on AIDS and...Elizabeth Glaser Pediatric AIDS FoundationCompletedPartner HIV Testing | Couple HIV Counseling | Couple Communication | HIV IncidenceCameroon, Dominican Republic, Georgia, India
-
ANRS, Emerging Infectious DiseasesHopital Universitaire Robert-Debre; Institut de Recherche pour le Developpement and other collaboratorsUnknownHIV | HIV-uninfected Children | Children Exposed to HIVCameroon
-
University of MinnesotaWithdrawnHIV Infections | HIV/AIDS | Hiv | AIDS | Aids/Hiv Problem | AIDS and InfectionsUnited States
-
CDC FoundationGilead SciencesUnknownHIV Preexposure Prophylaxis | HIV ChemoprophylaxisUnited States
-
Africa Health Research InstituteLondon School of Hygiene and Tropical Medicine; University College, London; University... and other collaboratorsRecruiting
-
Massachusetts General HospitalNational Institute of Mental Health (NIMH); Fenway Community Health; Tuberculosis...CompletedHIV/STI Risk | HIV/STI IncidenceUnited States, India
-
Erasmus Medical CenterNot yet recruitingHIV Infections | Hiv | HIV-1-infection | HIV I InfectionNetherlands
-
University of WashingtonNational Institute of Mental Health (NIMH)RecruitingHIV Prevention | HIV Preexposure Prophylaxis | ImplementationKenya
-
University of Maryland, BaltimoreWithdrawnHiv | Kidney Transplant | HIV Reservoir | CCR5United States
Clinical Trials on Life Steps for Medication Adherence
-
Massachusetts General HospitalNational Institute of Mental Health (NIMH)CompletedDepression | HIV Infections | HIVUnited States
-
Rush University Medical CenterEunice Kennedy Shriver National Institute of Child Health and Human Development...Completed
-
Fenway Community HealthMassachusetts General Hospital; Brown University; Emory University; University... and other collaboratorsCompletedHIV | Medication Adherence | Pre-exposure ProphylaxisUnited States
-
Janssen-Cilag Pty LtdCompletedSchizophrenia | Schizoaffective Disorder
-
University of Missouri, Kansas CityCompletedCardiovascular DiseaseUnited States
-
Brigham and Women's HospitalUniversity of WaterlooCompleted
-
The Hong Kong Polytechnic UniversityCastle Peak Hospital; Kwai Chung Hospital, Hong KongCompletedSchizophrenia | Schizoaffective Disorder | Schizophreniform DisorderHong Kong
-
Brigham and Women's HospitalNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Completed
-
University of California, San FranciscoNational Institute of Nursing Research (NINR)Completed
-
Makerere UniversityCompletedHuman Immunodeficiency VirusUganda